Drug Type Small molecule drug |
Synonyms |
Target |
Action inhibitors |
Mechanism LSF inhibitors(transcription factor CP2 inhibitors) |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Colorectal Cancer | Preclinical | United States | 15 Aug 2020 | |
| Hepatocellular Carcinoma | Preclinical | United States | 15 Aug 2020 | |
| Pancreatic Cancer | Preclinical | United States | 15 Aug 2020 |





